In Memoriam: Rosenborg Mourns the Loss of Valued Colleague Erlend Olsbø Berre
Rosenborg Ballklub has announced with profound sadness the passing of one of its own, beloved colleague Erlend Olsbø Berre, aged 36. The news was confirmed on the club’s official website on Monday.
Erlend’s journey with Rosenborg began in 2013 as a part-time employee at Trondheims-Ørn. He joined the club professionally in October 2018, just ahead of the opening of Lerkendal Stadion‘s Koteng Arena.
"Rosenborg has lost a mainstay," the club stated. "Erlend leaves a significant void in our organization and at Koteng Arena. We are grateful for everything he was and contributed to the club. A football coach, player, eternal optimist, cook, equipment manager, and an all-around multifaceted individual, Erlend will be deeply missed."
Dagbladet has reached out to Rosenborg’s media chief Jørgen Stenseth, who confirmed that next of kin have been informed regarding the public remembrance.
Worth a look
- Singapore LTA Unveils Completed RTS Station Design
- Thailand Urges Law Reform to Tackle Low Birth Rate and Quality Crisis
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)